SIGNAL TRANSDUCTION FROM THE T-CELL ANTIGEN RECEPTOR
SIGNAL TRANSDUCTION FROM THE T-CELL ANTIGEN RECEPTOR
批准号:
3306743
负责人:
ROBERT T ABRAHAM
金额:
$15.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-05-01 至 1996-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract): The cascade of molecular
events that link cell surface ligand-receptor interactions to regulated
changes in cellular functions are only partially understood. The T-cell
antigen receptor (TCR) is a multimeric complex, which includes the CD3
complex that serves as the primary recognition and signal-transducing
element during specific T-cell activation. Triggering of the TCR by
activating ligands stimulates a pleiotropic activation response culminating
in cell growth and differentiation. A prototypical early (minutes)
response to TCR ligation is the exocytosis of cytoplasmic granules from
cytolytic T-lymphocytes (CTL).
The long-term goals of this project are to define the mechanisms of
transmembrane signal generation and propagation initiated by TCR ligation.
Recent studies indicate that an undefined protein tyrosine kinase serves as
the proximal signal-transducing element from ligand-bound TCR.A critical
substrate for this TCR-coupled protein tyrosine kinase is phosphoinositide-
specific phospholipase C (PLC-gamma1). The specific aims of this proposal
are the following: (1) To identify the protein tyrosine kinase that
couples TCR-ligation to the tyrosine phosphorylation of PLC-gamma1; (2) to
determine the effect of altered PLC-gamma1 isozyme expression on signal
transduction through the TCR; and (3) to examine the role of protein
tyrosine kinase activation and p21ras in TCR-dependent granule exocytosis
in cytolytic T-cells. The investigator indicates that the results of this
study should offer novel insights into transmembrane signalling mechanisms
involved in both normal cell growth and cellular transformation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
KINASE TARGETS IN HYPOXIC CANCER CELLS
-
批准号:6923492
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2005
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Developmental Pilot Project 2
-
批准号:6990460
-
项目类别:
-
资助金额:$4.43万
-
财政年份:2004
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Roles of ATM and ATR Kinases in DNA Damage Responses
-
批准号:6640664
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2002
-
负责人:ROBERT T ABRAHAM
-
依托单位:
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY
-
批准号:6650587
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2002
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Roles of ATM and ATR Kinases in DNA Damage Responses
-
批准号:6555197
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2002
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Roles of ATM and ATR Kinases in DNA Damage Responses
-
批准号:6706268
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2002
-
负责人:ROBERT T ABRAHAM
-
依托单位:
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY
-
批准号:6496689
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2001
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6300373
-
项目类别:
-
资助金额:$16.56万
-
财政年份:2000
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6102644
-
项目类别:
-
资助金额:$16.56万
-
财政年份:1999
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL-CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6269456
-
项目类别:
-
资助金额:$15.96万
-
财政年份:1998
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:6124431
-
项目类别:
-
资助金额:$21.11万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:2448920
-
项目类别:
-
资助金额:$18.49万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:2837767
-
项目类别:
-
资助金额:$20.49万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Cellular Pharmacology of Rapamycin
-
批准号:6574185
-
项目类别:
-
资助金额:$33.6万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CANCER CENTER SUPPORT GRANT
-
批准号:6768018
-
项目类别:
-
资助金额:$340.0万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Cellular Pharmacology of Rapamycin
-
批准号:6712826
-
项目类别:
-
资助金额:$33.6万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:6617287
-
项目类别:
-
资助金额:$14.78万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL-CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6237156
-
项目类别:
-
资助金额:$15.36万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:6329001
-
项目类别:
-
资助金额:$6.96万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
SIGNAL TRANSDUCTION FROM THE T CELL ANTIGEN RECEPTOR
-
批准号:2184688
-
项目类别:
-
资助金额:$19.13万
-
财政年份:1992
-
负责人:ROBERT T ABRAHAM
-
依托单位:
海外基金